Trial intelligence / Profile preview

Vitamin D supplementation in chronic hepatitis C and effects on fibrotic cytokine responses

TCTR20161103003Phase 4Completed

Sponsor
Chulalongkorn University
Start
Nov 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vitamin d in chronic hepatitis C (CHC), Vitamin D deficiency (VDD), sponsored by Chulalongkorn University. Started Nov 2014; status: completed.

02

Drugs

vitamin d
03

Conditions

chronic hepatitis C (CHC)Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on TCTR20161103003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20161103003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call